A detailed history of Park Place Capital Corp transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Park Place Capital Corp holds 13,362 shares of BMY stock, worth $745,198. This represents 0.22% of its overall portfolio holdings.

Number of Shares
13,362
Previous 8,853 50.93%
Holding current value
$745,198
Previous $367,000 88.28%
% of portfolio
0.22%
Previous 0.13%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$39.66 - $51.75 $178,826 - $233,340
4,509 Added 50.93%
13,362 $691,000
Q2 2024

Jul 02, 2024

BUY
$40.25 - $52.99 $4,588 - $6,040
114 Added 1.3%
8,853 $367,000
Q1 2024

Apr 18, 2024

BUY
$47.98 - $54.4 $243,882 - $276,515
5,083 Added 139.03%
8,739 $473,000
Q4 2023

Jan 24, 2024

SELL
$48.48 - $57.85 $85,664 - $102,220
-1,767 Reduced 32.58%
3,656 $187,000
Q3 2023

Oct 17, 2023

SELL
$57.89 - $64.73 $109,991 - $122,987
-1,900 Reduced 25.95%
5,423 $314,000
Q2 2023

Aug 04, 2023

BUY
$63.71 - $70.74 $101,107 - $112,264
1,587 Added 27.67%
7,323 $468,000
Q1 2023

May 02, 2023

BUY
$65.71 - $74.53 $34,563 - $39,202
526 Added 10.1%
5,736 $397,000
Q4 2022

Feb 14, 2023

BUY
$68.48 - $81.09 $356,780 - $422,478
5,210 New
5,210 $375,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $119B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Park Place Capital Corp Portfolio

Follow Park Place Capital Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Park Place Capital Corp, based on Form 13F filings with the SEC.

News

Stay updated on Park Place Capital Corp with notifications on news.